Production in Australia)



Seqirus markets and distributes a number of vaccines and pharmaceutical products to ensure a comprehensive range of products are available to the New Zealand market.

Information on our products is intended for use by New Zealand:
  • Healthcare professionals who want to know more about a Seqirus product,
  • and Individuals who have been prescribed a Seqirus product

A-Z of New Zealand products

Afluria® Quad | Inactivated Quadrivalent Influenza vaccine (split viron)

For the prevention of influenza in persons aged 5 years and over.

ADT™ Booster | Diphtheria and Tetanus vaccine (adsorbed)

For the prevention of diphtheria and tetanus.

BCG Vaccine SSI | Live attenuated Mycobacterium bovis BCG (Bacillus Calmette-Guerin) vaccine

For active immunisation against tuberculosis.

Dukoral® | Oral inactivated cholera vaccine

For prevention of cholera and of travellers’ diarrhoea caused by serogroup O1 Vibrio cholera and heat-labile toxin-producing enterotoxigenic Escherichia coli (ETEC).

Gardasil® 9 | Human Papillomavirus 9-valent (Types 6, 11, 16, 18, 31, 33, 45, 52, 58) vaccine, Recombinant

In women aged 9-45 years, for the prevention of cervical, vulvar, vaginal and anal cancer, precancerous or dysplastic lesions, genital warts and infection caused by Human Papillomavirus (HPV) types 6, 11, 16, 18, 31, 45, 52 and 58. In men aged 9-26 years for the prevention of anal cancer, precancerous or dysplastic lesions, external genital lesions and infection caused by HPV types 6, 11, 16, 18, 31, 33, 45, 52 and 58.

Jespect® | Inactivated Japanese Encephalitis vaccine

For the prevention of Japanese Encephalitis infection.

Tramal® | Tramadol Hydrochloride
Vimpat® | Lacosamide
Vivotif® Oral | Oral, live, attenuated Typhoid vaccine

DUKORAL® and JESPECT® are registered trademarks of Valneva Sweden AB.
GARDASIL® 9 is a registered trademark of Merck & Co. Inc Whitehouse Station, NJ, USA.
TRAMAL® is a registered trademark of Grunenthal GmbH used by Seqirus as authorised user.
VIMPAT® is a registered trademark used by UCB Pharma GmbH under license.
VIVOTIF® is a Registered Trademark of PaxVax Berna GmbH, Switzerland.
All other trademarks are registered by Seqirus UK Limited or its affiliates in one or more jurisdictions.

Pandemic Response Solutions

As a global leader in influenza vaccine manufacturing, Seqirus offers a portfolio of pandemic vaccines and services which are tailored to rapid response.
Learn more





Our research is focused on enhancing our technologies available today while also working transformational approaches to influenza protection for the future.

Learn more

We are driven to transform influenza protection around the world through the development of innovative influenza vaccine technologies and pandemic response solutions.

Learn more

Questions or concerns? Find the best way to reach us here.

Learn more